MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

ON 146040

CAS No. : 1404231-34-0

MCE 站：ON 146040

产品活性：ON 146040 是一种有效的 PI3Kα 和 PI3Kδ 抑制剂，IC₅₀ 分别约为 14 和 20 nM。ON 146040 也抑制 Abl1 (IC₅₀<150 nM)。

研究领域：PI3K/Akt/mTOR  |  Protein Tyrosine Kinase/RTK

作用靶点：PI3K  |  Bcr-Abl

In Vitro: In biochemical testing, ON 146040 inhibits PI3Kα/ PI3Kδ isoforms (IC₅₀≈14 ａnd 20 nM, respectively) without having a major effect on PI3Kβ/ PI3Kγ isoforms (IC₅₀≈3 ａnd 1 μM, respectively). ON 146040 is also found to inhibit Abl1 ａnd several mutant versions of this kinase (IC₅₀<150 nM), although ON 146040 is not found to be active against the T315I mutant. ON 146040 represents the first dual PI3K ａnd BCR-ABL inhibitor that targets the STAT3 ａnd STAT5 pathways. ON 146040 disrupts the oncogenic activity of both STAT3 ａnd STAT5 by targeting upstream activators, including PI3K α ａnd δ isoforms as well as wild type ａnd mutant BCR-ABL. ON 146040 is highly potent in killing hematologic tumor cells with IC₅₀ values in the 150 to 1,000 nM range. Following treatment with ON 146040, STAT3 ａnd STAT5 phosphorylation are down-regulated in leukemia ａnd myeloma cells.

相关产品：3-Methyladenine  |  LY294002  |  Alpelisib  |  Dasatinib  |  Quercetin  |  Wortmannin  |  Nocodazole  |  740 Y-P  |  Imatinib  |  Ponatinib  |  Idelalisib  |  Buparlisib  |  Nilotinib  |  Eganelisib  |  Dactolisib  |  Copanlisib  |  Pictilisib  |  Bosutinib  |  SAR405  |  GDC-0077  |  Duvelisib  |  Fimepinostat  |  Degrasyn  |  Omipalisib  |  PI-103  |  Taselisib  |  YM-201636  |  Recilisib  |  Isorhamnetin

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。